Beta-2 adrenergic receptor in CD8+ T cells inhibits GVHD through transcriptional modulation of differentiation and exhaustion.
Allogeneic hematopoietic cell transplantation (allo-HCT) is an effective therapy for selected hematologic diseases. However, graft-versus-host disease (GVHD) limits broader application of allo-HCT. The catecholaminergic sympathetic nervous system modulates immune cells. Beta-2 adrenergic Receptor (β2AR) acts as an immu...